• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025

    5/15/25 5:00:00 PM ET
    $NOVT
    Industrial Machinery/Components
    Miscellaneous
    Get the next $NOVT alert in real time by email

    Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025, in New York, NY.

    About Novanta

    Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to solve complex technical challenges. This enables Novanta to engineer proprietary technology solutions that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation, the Novanta Growth System, and our customers' success. Novanta's common shares are quoted on Nasdaq under the ticker symbol "NOVT."

    More information about Novanta is available on the Company's website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or [email protected].

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250515291311/en/

    Novanta Inc.

    Investor Relations Contact:

    Ray Nash

    (781) 266-5137

    Get the next $NOVT alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NOVT

    DatePrice TargetRatingAnalyst
    5/11/2022Mkt Perform → Outperform
    William Blair
    More analyst ratings

    $NOVT
    SEC Filings

    See more
    • Novanta Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities

      8-K - NOVANTA INC (0001076930) (Filer)

      6/9/25 4:30:36 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

      8-K - NOVANTA INC (0001076930) (Filer)

      6/2/25 4:00:09 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SD filed by Novanta Inc.

      SD - NOVANTA INC (0001076930) (Filer)

      5/30/25 4:00:09 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous

    $NOVT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Novanta to Present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025

      Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at the CJS Securities 25th Annual New Ideas Summer Conference on Thursday, July 10, 2025, in White Plains, New York. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven a

      6/12/25 5:00:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta to Present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025

      Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Robert Buckley, Chief Financial Officer, is scheduled to present at Baird 2025 Global Consumer, Technology & Services Conference on Wednesday, June 4, 2025, in New York, NY. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to

      5/15/25 5:00:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta to Present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025

      Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer is scheduled to present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025, in Chicago, IL. About Novanta Novanta is a leading global supplier of core technology solutions that give medical, life science, and advanced industrial original equipment manufacturers a competitive advantage. We combine deep proprietary expertise and competencies in precision medicine, precision manufacturing, robotics and automation, and advanced surgery with a proven ability to s

      5/13/25 5:00:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous

    $NOVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Johnson Robert Matthew converted options into 818 shares (SEC Form 4)

      4 - NOVANTA INC (0001076930) (Issuer)

      5/12/25 4:05:51 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Co-Chief Operating Officer Ravetto Charles Guy Jr converted options into 9,421 shares and covered exercise/tax liability with 3,418 shares, increasing direct ownership by 84% to 13,162 units (SEC Form 4)

      4 - NOVANTA INC (0001076930) (Issuer)

      4/23/25 6:14:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Chief Financial Officer Buckley Robert converted options into 5,425 shares and covered exercise/tax liability with 2,623 shares, increasing direct ownership by 3% to 91,034 units (SEC Form 4)

      4 - NOVANTA INC (0001076930) (Issuer)

      2/26/25 5:59:48 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous

    $NOVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Novanta upgraded by William Blair

      William Blair upgraded Novanta from Mkt Perform to Outperform

      5/11/22 6:19:56 AM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous

    $NOVT
    Financials

    Live finance-specific insights

    See more
    • Novanta Announces Financial Results for the First Quarter 2025

      First Quarter 2025 GAAP Revenue increased 1% to $233 million First Quarter 2025 GAAP Diluted Earnings Per Share of $0.59 and Adjusted EPS of $0.74 First Quarter 2025 GAAP Net Income increased 45% to $21 million First Quarter 2025 Adjusted EBITDA increased 1% to $50 million First Quarter 2025 Operating Cash Flow of $32 million Company reiterates Full Year 2025 Adjusted EBITDA guidance Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the first quarter 2025. Financial Highlights Three Months Ended   (In millions, except per share amoun

      5/6/25 7:00:00 AM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, May 6, 2025

      Novanta Inc. (NASDAQ:NOVT) (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, will release its first quarter 2025 results on Tuesday, May 6, 2025. The Company will host a conference call on Tuesday, May 6, 2025, at 10:00 a.m. ET to discuss these results. To access the call, please dial (888) 346-3959 before the scheduled conference call time. Alternatively, the conference call can be accessed online via a live webcast on the Events & Presentations page of the Investors section of the Company's website at www.novanta.com. A replay of the audio webcast will be available approximately three hours after the conclusion of the call on the E

      4/8/25 5:00:00 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • Novanta Announces Financial Results for the Fourth Quarter and Full Year 2024

      Fourth Quarter 2024 GAAP Revenue increased 13% to $238 million, including $2 million unfavorable FX impact Fourth Quarter 2024 GAAP Diluted EPS of $0.46 and Adjusted EPS of $0.76 Full Year 2024 GAAP Revenue increased 8% to $949 million Full Year 2024 GAAP Diluted EPS of $1.77, and Adjusted EPS of $3.08 Full Year 2024 Adjusted EBITDA increased 7% to $210 million Full Year 2024 Operating Cash Flow increased 32% to $159 million Novanta Inc. (NASDAQ:NOVT) ("Novanta" or the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, today reported financial results for the fourth quarter and full year 2024. Financial Highlights

      2/25/25 7:00:00 AM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous

    $NOVT
    Leadership Updates

    Live Leadership Updates

    See more
    • IDEX Corporation Appoints Stephanie Disher and Matthijs Glastra to Board of Directors; David Parry and Livingston Satterthwaite to Retire

      IDEX Corporation (NYSE:IEX) today announced the appointment of Stephanie ("Steph") Disher and Matthijs Glastra to the company's Board of Directors. The appointments, effective Friday, February 21, 2025, increase the size of the Board from 10 to 12 directors. Ms. Disher will serve on the Board's Nominating and Corporate Governance Committee, and Mr. Glastra will serve on the Board's Audit Committee. Ms. Disher currently serves as Chief Executive Officer of Atmus Filtration Technologies Inc. (NYSE:ATMU), a leader in filtration and media solutions. She has extensive global leadership experience in finance and operations from her time at Atmus, Cummins Inc. and BP, p.l.c. Mr. Glastra currentl

      2/20/25 5:07:00 PM ET
      $ATMU
      $IEX
      $NOVT
      Auto Parts:O.E.M.
      Consumer Discretionary
      Fluid Controls
      Industrials
    • Politan Details Why a Truly Independent Board is Urgently Needed at Masimo in Order to Protect Shareholder Value and Realize the Company's Full Potential

      Sends Letter to Masimo Shareholders and Releases 160-Page Investor Presentation Urges Shareholders to Help Deliver Immediate Change by Voting for Both of Politan's Independent and Ideally Qualified Nominees Darlene Solomon and William Jellison on the WHITE Card Shareholders Can Visit www.AdvanceMasimo.com for Further Information Politan Capital Management (together with its affiliates, "Politan"), an 8.9% shareholder of Masimo Corporation ("Masimo" or the "Company") (NASDAQ:MASI), today sent a letter to the Company's shareholders outlining why a majority of truly independent directors are urgently needed in the Masimo boardroom. Politan also released a detailed investor presentation m

      6/26/24 8:00:00 AM ET
      $A
      $ANIK
      $AVNT
      $MASI
      Biotechnology: Laboratory Analytical Instruments
      Industrials
      Medical/Dental Instruments
      Health Care

    $NOVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Novanta Inc.

      SC 13G/A - NOVANTA INC (0001076930) (Subject)

      11/14/24 1:22:36 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G filed by Novanta Inc.

      SC 13G - NOVANTA INC (0001076930) (Subject)

      2/14/24 10:02:59 AM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous
    • SEC Form SC 13G/A filed by Novanta Inc. (Amendment)

      SC 13G/A - NOVANTA INC (0001076930) (Subject)

      2/13/24 5:09:44 PM ET
      $NOVT
      Industrial Machinery/Components
      Miscellaneous